UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 270

Sortiert nach

G-CSF-primed bone marrow as a source of stem cells for allografting: revisiting the concept

Bone marrow transplantation (Basingstoke), 2015-09, Vol.50 (9), p.1150-1156

2015

Volltextzugriff (PDF)

Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemia

Leukemia, 2015-03, Vol.29 (3), p.526-534

2015

Volltextzugriff (PDF)

Risk factors for catheter‐related thrombosis (CRT) in cancer patients: a patient‐level data (IPD) meta‐analysis of clinical trials and prospective studies

Journal of thrombosis and haemostasis, 2011-02, Vol.9 (2), p.312-319

2011

Volltextzugriff (PDF)

A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies

Blood, 2002-09, Vol.100 (5), p.1525-1531

2002

Volltextzugriff (PDF)

Treatment outcomes for older patients with relapsed/refractory aggressive lymphoma receiving salvage chemotherapy and autologous stem cell transplantation are similar to younger patients: a subgroup analysis from the phase III CCTG LY.12 trial

Annals of oncology, 2017-03, Vol.28 (3), p.622-627

2017

Volltextzugriff (PDF)

Characteristics predicting outcomes of allogeneic stem-cell transplantation in relapsed acute myelogenous leukemia

Current oncology (Toronto), 2017-04, Vol.24 (2), p.e123-130

2017

Volltextzugriff (PDF)

A prospective cohort study of the feasibility and efficacy of iron reduction by phlebotomy in recipients of hematopoietic SCT

Bone marrow transplantation (Basingstoke), 2015-03, Vol.50 (3), p.457-458

2015

Volltextzugriff (PDF)

Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin’s disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group

Annals of oncology, 2003-12, Vol.14 (12), p.1762-1767

2003

Volltextzugriff (PDF)

Low molecular weight heparin for the prevention of hepatic veno-occlusive disease (VOD) after hematopoietic stem cell transplantation: a prospective phase II study

Bone marrow transplantation (Basingstoke), 2003-06, Vol.31 (12), p.1143-1149

2003

Volltextzugriff (PDF)

Duration of first remission and hematopoietic cell transplantation-specific comorbidity index but not age predict survival of patients with AML transplanted in CR2: a retrospective multicenter study

Bone marrow transplantation (Basingstoke), 2016-07, Vol.51 (7), p.1019-1021

2016

Volltextzugriff (PDF)

A Canadian consensus on the management of newly diagnosed and relapsed acute promyelocytic leukemia in adults

Current oncology (Toronto), 2014-10, Vol.21 (5), p.234-250

2014

Volltextzugriff (PDF)

Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with Philadelphia chromosome-positive or BCR-ABL-positive acute lymphoblastic leukemia: a Canadian consensus

Current oncology (Toronto), 2014-04, Vol.21 (2), p.e265-309

2014

Volltextzugriff (PDF)

Non-myeloablative allogeneic hematopoietic transplantation for patients with hematologic malignancies: 9-year single-centre experience

Current oncology (Toronto), 2014-06, Vol.21 (3), p.e434-440

2014

Volltextzugriff (PDF)

Outcomes of reduced-intensity conditioning allo-SCT for Hodgkin's lymphoma: a national review by the Canadian Blood and Marrow Transplant Group

Bone marrow transplantation (Basingstoke), 2010-07, Vol.45 (7), p.1253-1255

2010

Volltextzugriff (PDF)

Central nervous system graft-versus-host disease presenting with granulomatous encephalitis

Bone marrow transplantation (Basingstoke), 2007-07, Vol.40 (2), p.183-184

2007

Volltextzugriff (PDF)

PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews

Systematic reviews, 2021-01, Vol.10 (1), p.39-39, Article 39

2021

Volltextzugriff (PDF)

Arteriovenous fistula formation in a volunteer allogeneic peripheral blood progenitor cell donor

Bone marrow transplantation (Basingstoke), 2007-09, Vol.40 (5), p.501-502

2007

Volltextzugriff (PDF)

Apixaban to Prevent Venous Thromboembolism in Patients with Cancer

The New England journal of medicine, 2019-02, Vol.380 (8), p.711-719

2019

Volltextzugriff (PDF)

Randomized Placebo-Controlled Study of Low-Dose Warfarin for the Prevention of Central Venous Catheter–Associated Thrombosis in Patients With Cancer

Journal of clinical oncology, 2005-06, Vol.23 (18), p.4063-4069

2005

Volltextzugriff (PDF)

Screening for Occult Cancer in Unprovoked Venous Thromboembolism

The New England journal of medicine, 2015-08, Vol.373 (8), p.697-704

2015

Volltextzugriff (PDF)

Allogeneic Peripheral Blood Stem-Cell Compared With Bone Marrow Transplantation in the Management of Hematologic Malignancies: An Individual Patient Data Meta-Analysis of Nine Randomized Trials

Journal of clinical oncology, 2005-08, Vol.23 (22), p.5074-5087

Stem Cell Trialists' Collaborative Group

2005

Volltextzugriff (PDF)

Confusion of drug names signalled

Canadian Medical Association journal (CMAJ), 1995-06, Vol.152 (11), p.1749

Couban, S

1995

Volltextzugriff (PDF)

An unusual presentation of extramedullary plasmacytoma occurring sequentially in the testis, subcutaneous tissue, and heart

American journal of hematology, 2001-07, Vol.67 (3), p.194-196

2001

Volltextzugriff (PDF)

Allogeneic hematopoietic stem cell transplantation for progressive follicular lymphoma

Bone marrow transplantation (Basingstoke), 2002-06, Vol.29 (12), p.973-978

2002

Volltextzugriff (PDF)

Monitoring soluble interleukin-2 receptor levels in related and unrelated donor allogeneic bone marrow transplantation

Bone marrow transplantation (Basingstoke), 1998-04, Vol.21 (8), p.769-773

1998

Volltextzugriff (PDF)

1 – 25 von 270

Suche als RSS-Feed

Aktive Filter

KollektionBMJ Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(242)
Mit Volltextzugriff
(244)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

G-CSF-primed bone marrow as a source of stem cells for allografting: revisiting the concept

Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemia

Risk factors for catheter‐related thrombosis (CRT) in cancer patients: a patient‐level data (IPD) meta‐analysis of clinical trials and prospective studies

A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies

Treatment outcomes for older patients with relapsed/refractory aggressive lymphoma receiving salvage chemotherapy and autologous stem cell transplantation are similar to younger patients: a subgroup analysis from the phase III CCTG LY.12 trial

Characteristics predicting outcomes of allogeneic stem-cell transplantation in relapsed acute myelogenous leukemia

A prospective cohort study of the feasibility and efficacy of iron reduction by phlebotomy in recipients of hematopoietic SCT

Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin’s disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group

Low molecular weight heparin for the prevention of hepatic veno-occlusive disease (VOD) after hematopoietic stem cell transplantation: a prospective phase II study

Duration of first remission and hematopoietic cell transplantation-specific comorbidity index but not age predict survival of patients with AML transplanted in CR2: a retrospective multicenter study

A Canadian consensus on the management of newly diagnosed and relapsed acute promyelocytic leukemia in adults

Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with Philadelphia chromosome-positive or BCR-ABL-positive acute lymphoblastic leukemia: a Canadian consensus

Non-myeloablative allogeneic hematopoietic transplantation for patients with hematologic malignancies: 9-year single-centre experience

Outcomes of reduced-intensity conditioning allo-SCT for Hodgkin's lymphoma: a national review by the Canadian Blood and Marrow Transplant Group

Central nervous system graft-versus-host disease presenting with granulomatous encephalitis

PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews

Arteriovenous fistula formation in a volunteer allogeneic peripheral blood progenitor cell donor

Apixaban to Prevent Venous Thromboembolism in Patients with Cancer

Randomized Placebo-Controlled Study of Low-Dose Warfarin for the Prevention of Central Venous Catheter–Associated Thrombosis in Patients With Cancer

Screening for Occult Cancer in Unprovoked Venous Thromboembolism

Allogeneic Peripheral Blood Stem-Cell Compared With Bone Marrow Transplantation in the Management of Hematologic Malignancies: An Individual Patient Data Meta-Analysis of Nine Randomized Trials

Confusion of drug names signalled

An unusual presentation of extramedullary plasmacytoma occurring sequentially in the testis, subcutaneous tissue, and heart

Allogeneic hematopoietic stem cell transplantation for progressive follicular lymphoma

Monitoring soluble interleukin-2 receptor levels in related and unrelated donor allogeneic bone marrow transplantation

Aktive Filter

Suchergebnisse filtern